Wikisage, the free encyclopedia of the second generation, is digital heritage

Brivaracetam

From Wikisage
Revision as of 01:58, 10 July 2019 by Penarc (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


4n propyl analog of levetiracetam, this and levetiracetam may have potential in the management of progressive myoclonic epilepsies [1][2]Like levetiracetam (LEV), it is a ligand of the synaptic vesicle protein SV2A[3]

Links

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm486827.htm


An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam


ATC

  • (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide

    (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide

brivaracetam
[4]


Q408099 at Wikidata  Interwiki via Wikidata


  1. ↑ Profile of brivaracetam and its potential in the treatment of epilepsy
  2. ↑ Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset
  3. ↑ Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base
  4. ↑ http://www.whocc.no/atc_ddd_index/?code=N03AX23
Retrieved from "https://en.wikisage.org/w/index.php?title=Brivaracetam&oldid=9593"